DK0661051T3 - Medikament til behandling af hypertension - Google Patents

Medikament til behandling af hypertension

Info

Publication number
DK0661051T3
DK0661051T3 DK94115833T DK94115833T DK0661051T3 DK 0661051 T3 DK0661051 T3 DK 0661051T3 DK 94115833 T DK94115833 T DK 94115833T DK 94115833 T DK94115833 T DK 94115833T DK 0661051 T3 DK0661051 T3 DK 0661051T3
Authority
DK
Denmark
Prior art keywords
platelets
product
medication
treat hypertension
smokers
Prior art date
Application number
DK94115833T
Other languages
Danish (da)
English (en)
Inventor
Peter Dr Koeltringer
Original Assignee
Viatris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viatris Gmbh filed Critical Viatris Gmbh
Application granted granted Critical
Publication of DK0661051T3 publication Critical patent/DK0661051T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
DK94115833T 1993-10-11 1994-10-07 Medikament til behandling af hypertension DK0661051T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT204593 1993-10-11
AT209493 1993-10-18

Publications (1)

Publication Number Publication Date
DK0661051T3 true DK0661051T3 (da) 2006-05-22

Family

ID=25597506

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94115833T DK0661051T3 (da) 1993-10-11 1994-10-07 Medikament til behandling af hypertension

Country Status (9)

Country Link
US (1) US5532269A (fr)
EP (1) EP0661051B1 (fr)
JP (2) JP3370795B2 (fr)
AT (1) ATE315391T1 (fr)
CA (1) CA2133861C (fr)
DE (1) DE59410426D1 (fr)
DK (1) DK0661051T3 (fr)
ES (1) ES2256838T3 (fr)
PT (1) PT661051E (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4439477C2 (de) * 1994-11-08 1999-10-21 Asta Medica Ag Verwendung von R,S-(+/-)-alpha-Liponsäure, R-(+)-alpha-Liponäure, S-(-)-alpha-Liponsäure in reduzierter oder oxidierter Form oder der Metabolite sowie deren Salze, Ester, Amide zur Behandlung der diabetischen Mikroangiopathie
US5962030A (en) 1997-03-07 1999-10-05 Akesis Pharmaceuticals, Inc. Dietary supplement and method of treatment for diabetic control
US5990153A (en) * 1997-05-05 1999-11-23 Wood; John G. Ultrasonicated α-lipoic acid solutions for attenuating microvascular injury
GB9715444D0 (en) 1997-07-22 1997-09-24 Scotia Holdings Plc Therapeutic and dietary compositions
US6090842A (en) * 1998-03-10 2000-07-18 The Regents Of The University Of California Lipoic acid analogs
US20050085498A1 (en) * 1998-05-28 2005-04-21 Byrd Edward A. Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and L-arginine alpha-ketoglutarate
US20040259895A1 (en) * 1998-05-28 2004-12-23 Medical Research Institute Oral formulation of lipid soluble thiamine and lipoic acid
US6191162B1 (en) 1998-05-28 2001-02-20 Medical Research Institute Method of reducing serum glucose levels
US6197340B1 (en) 1998-05-28 2001-03-06 Medical Research Institute Controlled release lipoic acid
US6905707B2 (en) * 1998-05-28 2005-06-14 Medical Research Institute Controlled release arginine alpha ketoglutarate
US6376549B1 (en) * 1998-09-17 2002-04-23 Akesis Pharmaceuticals, Inc. Metforimin-containing compositions for the treatment of diabetes
WO2000015211A2 (fr) * 1998-09-17 2000-03-23 Akesis Pharmaceuticals, Inc. Compositions et traitements contre les troubles du metabolisme du glucose
US6573299B1 (en) 1999-09-20 2003-06-03 Advanced Medical Instruments Method and compositions for treatment of the aging eye
DE10027968A1 (de) * 2000-06-08 2001-12-13 Asta Medica Ag Mittel zur Therapie von Demenzen
US7030154B2 (en) * 2002-06-07 2006-04-18 Juvenon, Inc. Stability of lipoic acid
US6787163B2 (en) * 2003-01-21 2004-09-07 Dennis H. Harris Therapeutic treatment for blood sugar regulation
US7282225B1 (en) 2006-09-27 2007-10-16 Occular Technologies, Inc. Composition and methods for improving retinal health
US7943163B2 (en) 2007-08-22 2011-05-17 Response Scientific, Inc. Medical food or nutritional supplement, method of manufacturing same, and method of managing diabetes
US20090054513A1 (en) * 2007-08-22 2009-02-26 Response Scientific, Inc. Method of managing blood glucose levels, insulin levels and/or insulin receptor functionality in individuals with diabetes, polycystic ovarian syndrome and/or alzheimer's disease
CN107050438A (zh) * 2011-04-28 2017-08-18 碧恩股份有限公司 美肌促进剂及其利用
US20140065076A1 (en) * 2012-08-30 2014-03-06 Otsuka Pharmaceutical Co. Ltd. Container with concentrated substance and method of using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1213141B (it) * 1984-02-17 1989-12-14 Dobrivoje Tomic Composizioni farmaceutiche per il trattamento del diabete e di malattie e disfunzioni epatiche.
ATE93236T1 (de) * 1987-10-28 1993-09-15 Pro Neuron Inc Acylatiertes uridin und cytidin und deren verwendungen.
DE58902094D1 (de) * 1988-01-28 1992-10-01 Koeltringer Peter Kombinationspraeparat zur behandlung von nervenzell-und nervenfasererkrankungen und verletzungen.
EP0382066A3 (fr) * 1989-02-09 1992-01-08 ASTA Medica Aktiengesellschaft Utilisation de l'acide dihydroliponique comme agent analgésique, antiphlogistique et/ou cytoprotecteur
DE4002706A1 (de) * 1989-02-09 1990-08-16 Asta Pharma Ag Arzneimittel enthaltend als wirkstoff dihydroliponsaeure

Also Published As

Publication number Publication date
DE59410426D1 (de) 2006-04-06
EP0661051B1 (fr) 2006-01-11
EP0661051A2 (fr) 1995-07-05
JPH07206675A (ja) 1995-08-08
PT661051E (pt) 2006-05-31
US5532269A (en) 1996-07-02
ATE315391T1 (de) 2006-02-15
CA2133861A1 (fr) 1995-04-12
JP3370795B2 (ja) 2003-01-27
JP2002145772A (ja) 2002-05-22
CA2133861C (fr) 2004-03-30
EP0661051A3 (fr) 1995-10-18
ES2256838T3 (es) 2006-07-16

Similar Documents

Publication Publication Date Title
DK0661051T3 (da) Medikament til behandling af hypertension
KR950016783A (ko) 조절 방출용 약학 조성물
SE8402550L (sv) N-substituerade deridvat av moranolin
Willemse et al. Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy?
IL63122A (en) Antihistaminic tricyclic alkylcarbamic and sulfamic acid esters,their preparation and pharmaceutical compositions containing them
KR940005285A (ko) 염증성 장 질환, 염증성 피부 질환 및 자반증의 예방 및 치료용 약제제조를 위한 상보적 억제제의 용도
ES2029759A6 (es) Procedimiento para preparar derivados de naftalensulfonamida y de isoquinolinsulfonamida.
IT8920170A0 (it) Derivati fluorurati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono.
KR920021145A (ko) 뇌 글루타메이트의 과다방출의 억제에 유용한 제형
NO830727L (no) Metallkoplekser av dipeptid-soetningsstoffer
DK644388D0 (da) Farmaceutiske praeparater indeholdende 3-hydroxy-smoeresyrederivater
ES2173858T3 (es) Analogos de huperzina a.
NO177312C (no) Fremgangsmåte for fremstilling av hirudinderivater med forsinket virkning
GR3033742T3 (en) 10-DEACETYLBACCATINE III AND 10-DEACETYL 14-g(b)-HYDROXYBACCATINE III DERIVATIVES, A PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DK0666739T3 (da) Intravenøs opløsning som formindsker protein- og vandtab fra kroppen
KR880000575A (ko) 알파 1-안티 트립신의 변종
IL117816A0 (en) N-subsituted azaheterocyclic compounds their preparation and pharmaceutical compositions containing them
MX167786B (es) Composiciones de tiocarbonato, solidas, estabilizaas y metodos para elaborar las mismas
IT8721687A0 (it) Derivati dell'ossima della 1,2,5,6-tetraidropiridin-3-carbossa ldeide, loro procedimento di preparazione e loro impiego come sostanze medicinali.
DK1231908T3 (da) Farmaceutisk præparat, der omfatter en NO-donorforbindelse samt anvendelse heraf
KR920019356A (ko) 약제학적 조성물 및 그 제조방법
DE69331633D1 (de) Arzneimittel zur hemmung der neutrophilen elastase und cathepsin g
ATE241356T1 (de) Verlängerung der expression von transgenen proteinen durch immunmodulierende behandlung mit 15-deoxyspergualin
JPS55143912A (en) Useful preparation comprising bencyclane fumarate
JPS5226198A (en) Prevention of alarm error